Japan Generics Makers Turn Attention To Versions Of Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Several Japan-based makers of generic drugs are focusing increasingly on cancer drugs, many of them recently launching their versions of AstraZeneca's Arimidex (anastrozole) for treating breast cancer.